Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'NEUTRALIZING ANTIBODIES' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 846 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Grant, MD
      Antibody convergence along a common idiotypic axis in immunodeficiency virus and hepatitis C virus infections

      JOURNAL OF MEDICAL VIROLOGY
    2. Rocha-Zavaleta, L; Alejandre, JE; Garcia-Carranca, A
      Parenteral and oral immunization with a plasmid DNA expressing the human papillomavirus 16-L1 gene induces systemic and mucosal antibodies and cytotoxic T lymphocyte responses

      JOURNAL OF MEDICAL VIROLOGY
    3. Pal, R; Venzon, D; Letvin, NL; Santra, S; Montefiori, DC; Miller, NR; Tryniszewska, E; Lewis, MG; VanCott, TC; Hirsch, V; Woodward, R; Gibson, A; Grace, M; Dobratz, E; Markham, PD; Hel, Z; Nacsa, J; Klein, M; Tartaglia, J; Franchini, G
      ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency

      JOURNAL OF VIROLOGY
    4. Markine-Goriaynoff, D; Coutelier, JP
      Increased efficacy of the immunoglobulin G2a subclass in antibody-mediatedprotection against lactate dehydrogenase-elevating virus-induced polioencephalomyelitis revealed with switch mutants

      JOURNAL OF VIROLOGY
    5. Tian, HJ; Xiao, Y; Zhu, M; Chen, YH
      HIV epitope-peptides in aluminum adjuvant induced high levels of epitope-specific antibodies

      INTERNATIONAL IMMUNOPHARMACOLOGY
    6. Rahman, A; Tsai, V; Goudreau, A; Shinoda, JY; Wen, SF; Ramachandra, M; Ralston, R; Maneval, D; LaFace, D; Shabram, P
      Specific depletion of human anti-adenovirus antibodies facilitates transduction in an in vivo model for systemic gene therapy

      MOLECULAR THERAPY
    7. Nair, LG; Fraser-Reid, B; Szardenings, AK
      A versatile, three-component-reaction route to N-glycosylamines

      ORGANIC LETTERS
    8. Stern, PL; Faulkner, R; Veranes, EC; Davidson, EJ
      The role of human papillomavirus vaccines in cervical neoplasia

      BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY
    9. Anderson, DE; Carlos, MP; Nguyen, L; Torres, JV
      Overcoming original (antigenic) sin

      CLINICAL IMMUNOLOGY
    10. Schiller, JT; Lowy, DR
      Papillomavirus-like particle based vaccines: cervical cancer and beyond

      EXPERT OPINION ON BIOLOGICAL THERAPY
    11. Newkirk, MM; van Venrooij, WJ; Marshall, GS
      Autoimmune response to U1 small nuclear ribonucleoprotein (U1 snRNP) associated with cytomegalovirus infection

      ARTHRITIS RESEARCH
    12. Grabherr, R; Ernst, W
      The Baculovirus expression system as a tool for generating diversity by viral surface display

      COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
    13. Ruprecht, RM; Hofmann-Lehmann, R; Smith-Franklin, BA; Rasmussen, RA; Liska, V; Vlasak, J; Xu, W; Baba, TW; Chenine, AL; Cavacini, LA; Posner, MR; Katinger, H; Stiegler, G; Bernacky, BJ; Rizvi, TA; Schmidt, R; Hill, LR; Keeling, ME; Montefiori, DC; McClure, HM
      Protection of neonatal macaques against experimental SHIV infection by human neutralizing monoclonal antibodies

      TRANSFUSION CLINIQUE ET BIOLOGIQUE
    14. Busch, MP
      Insights into the epidemiology, natural history and pathogenesis of hepatitis C virus infection from studies of infected donors and blood product recipients

      TRANSFUSION CLINIQUE ET BIOLOGIQUE
    15. Perini, P; Facchinetti, A; Bulian, P; Massaro, AR; De Pascalis, D; Bertolotto, A; Biasi, G; Gallo, P
      Interferon-beta (IFN-beta) antibodies in interferon-beta 1a-and interferon-beta 1b-treated multiple sclerosis patients. Prevalence, kinetics, cross-reactivity, and factors enhancing interferon-beta immunogenicity in vivo

      EUROPEAN CYTOKINE NETWORK
    16. Xu, WD; Smith-Franklin, BA; Li, PL; Wood, C; He, J; Du, QJ; Bhat, GJ; Kankasa, C; Katinger, H; Cavacini, LA; Posner, MR; Burton, DR; Chou, TC; Ruprecht, RM
      Potent neutralization of primary human immunodeficiency virus clade C isolates with a synergistic combination of human monoclonal antibodies raised against clade B

      JOURNAL OF HUMAN VIROLOGY
    17. Eldridge, BF; Glaser, C; Pedrin, RE; Chiles, RE
      The first reported case of California encephalitis in more than 50 years

      EMERGING INFECTIOUS DISEASES
    18. Yao, SY; Ljunggren-Rose, A; Stratton, CW; Mitchell, WM; Sriram, S
      Regulation by IFN-beta of inducible nitric oxide synthase and interleukin-12/p40 in murine macrophages cultured in the presence of Chlamydia pneumoniae antigens

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    19. Chen, XN; Scala, G; Quinto, I; Liu, WM; Chun, TW; Justement, JS; Cohen, OJ; vanCott, TC; Iwanicki, M; Lewis, MG; Greenhouse, J; Barry, T; Venzon, D; Fauci, AS
      Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes

      NATURE MEDICINE
    20. Cohen, DE; Walker, BD
      Human immunodeficieny virus pathogenesis and prospects for immune control in patients with established infection

      CLINICAL INFECTIOUS DISEASES
    21. Piguet, V; Trono, D
      Living in oblivion: HIV immune evasion

      SEMINARS IN IMMUNOLOGY
    22. Passos, EC; Germano, PML; Guimaraes, MABV; Fedullo, JDL; Correa, SHR; Consales, CA; Carrieri, ML; Goncalves, MA
      Inactivated suckling mouse brain rabies vaccine provides short-term immunity in capuchin monkeys (Cebus apella)

      JOURNAL OF ZOO AND WILDLIFE MEDICINE
    23. Federoff, NE
      Antibody response to rabies vaccination in captive and free-ranging wolves(Canis lupus)

      JOURNAL OF ZOO AND WILDLIFE MEDICINE
    24. Jung, S; Chung, YK; Chang, SH; Kim, J; Kim, HR; Jang, HS; Lee, JC; Chung, GH; Jang, YS
      DNA-mediated immunization of glycoprotein 350 of Epstein-Barr virus induces the effective humoral and cellular immune responses against the antigen

      MOLECULES AND CELLS
    25. Ding, J; He, F; Lu, Y; Xiao, Y; Chen, YH
      Induction of multi-epitope-specific antibodies against HIV-1 by multi-epitope-vaccines

      CHINESE SCIENCE BULLETIN
    26. Akhurst, RJ; Derynck, R
      TGF-beta signaling in cancer - a double-edged sword

      TRENDS IN CELL BIOLOGY
    27. Mascola, JR; Nabel, GJ
      Vaccines for the prevention of HIV-1 disease

      CURRENT OPINION IN IMMUNOLOGY
    28. Tobiasch, E; Kehm, R; Bahr, U; Tidona, CA; Jakob, NJ; Handermann, M; Darai, G; Giese, M
      Large envelope glycoprotein and nucleocapsid protein of equine arteritis virus (EAV) induce an immune response in balb/c mice by DNA vaccination; Strategy for developing a DNA-vaccine against EAV-infection

      VIRUS GENES
    29. Enshell-Seijffers, D; Smelyanski, L; Vardinon, N; Yust, I; Gershoni, JM
      Dissection of the humoral immune response toward an immunodominant epitopeof HIV: a model for the analysis of antibody diversity in HIV plus individuals

      FASEB JOURNAL
    30. Patterson, LJ; Robey, F; Muck, A; Van Remoortere, K; Aldrich, K; Richardson, E; Alvord, WG; Markham, PD; Cranage, M; Robert-Guroff, M
      A conformational C4 peptide polymer vaccine coupled with live recombinant vector priming is immunogenic but does not protect against rectal SIV challenge

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    31. Ngo-Giang-Huong, N; Candotti, D; Goubar, A; Autran, B; Maynart, M; Sicard, D; Clauvel, JP; Agut, H; Costagliola, D; Rouzioux, C
      HIV type 1-specific IgG2 antibodies: Markers of helper T cell type 1 response and prognostic marker of long-term nonprogression

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    32. Lee, SC; Ibdah, R; Van Valkenburgh, C; Rowold, E; Abegg, A; Donnelly, A; Klover, J; Merlin, S; McKearn, JP
      Phage display mutagenesis of the chimeric dual cytokine receptor agonist myelopoietin

      LEUKEMIA
    33. Levine, M; Progulske-Fox, A; Denslow, ND; Farmerie, WG; Smith, DM; Swearingen, WT; Miller, FC; Liang, ZM; Roe, BA; Pan, HQ
      Identification of lysine decarboxylase as a mammalian cell growth inhibitor in Eikenella corrodens: possible role in periodontal disease

      MICROBIAL PATHOGENESIS
    34. Kolb, AF
      The prospects of modifying the antimicrobial properties of milk

      BIOTECHNOLOGY ADVANCES
    35. Schnell, MJ
      Viral vectors as potential HIV-1 vaccines

      FEMS MICROBIOLOGY LETTERS
    36. Gomez, CE; Esteban, M
      Recombinant proteins produced by vaccinia virus vectors can be incorporated within the virion (IMV form) into different compartments

      ARCHIVES OF VIROLOGY
    37. Bukh, J; Forns, X; Emerson, SU; Purcell, RH
      Studies of hepatitis C virus in chimpanzees and their importance for vaccine development

      INTERVIROLOGY
    38. Pupo-Antunez, M; Rodriguez, R; Alvarez, M; Amin, N; Rodriguez, H; Otero, A; Guzman, GR
      Development of a monoclonal antibody specific to a recombinant envelope protein from dengue virus type 4 expressed in Pichia pastoris

      HYBRIDOMA
    39. Ahmad, R; Sindhu, STAK; Toma, E; Morisset, R; Vincelette, J; Menezes, J; Ahmad, A
      Evidence for a correlation between antibody-dependent cellular cytotoxicity-mediating Anti-HIV-1 antibodies and prognostic predictors of HIV infection

      JOURNAL OF CLINICAL IMMUNOLOGY
    40. Lechmann, M; Murata, K; Satoi, J; Vergalla, J; Baumert, TF; Liang, TJ
      Hepatitis C virus-like particles induce virus-specific humoral and cellular immune responses in mice

      HEPATOLOGY
    41. Lenz, J; Su, M; Mizrachi, Y; Burke, M; Rubinstein, A
      V3 variation in HIV-seropositive patients receiving a V3-targeted vaccine

      AIDS
    42. Pu, RY; Coleman, A; Omori, M; Arai, M; Hohdatsu, T; Huang, CJ; Tanabe, T; Yamamoto, JK
      Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates

      AIDS
    43. Bolmstedt, A; Hinkula, J; Rowcliffe, E; Biller, M; Wahren, B; Olofsson, S
      Enhanced immunogenicity of a human immunodeficiency virus type 1 env DNA vaccine by manipulating N-glycosylation signals - Effects of elimination of the V3N306 glycan

      VACCINE
    44. Lee, SA; Orque, R; Escarpe, PA; Peterson, ML; Good, JW; Zaharias, EM; Berman, PW; Sheppard, HW; Shibata, R
      Vaccine-induced antibodies to the native, oligomeric envelope glycoproteins of primary HIV-1 isolates

      VACCINE
    45. Singh, M; Vajdy, M; Gardner, J; Briones, M; O'Hagan, D
      Mucosal immunization with HIV-1 gag DNA on cationic microparticles prolongs gene expression and enhances local and systemic immunity

      VACCINE
    46. Toledo, H; Baly, A; Castro, O; Resik, S; Laferte, J; Rolo, F; Navea, L; Lobaina, L; Cruz, O; Miguez, J; Serrano, T; Sierra, B; Perez, L; Ricardo, ME; Dubed, M; Lubian, AL; Blanco, M; Millan, JC; Ortega, A; Iglesias, E; Penton, E; Martin, Z; Perez, J; Diaz, M; Duarte, CA
      A phase I clinical trial of a mufti-epitope polypeptide TAB9 combined withMontanide ISA 720 adjuvant in non-HIV-1 infected human volunteers

      VACCINE
    47. Kowalczyk, DW; Wlazlo, AP; Shane, S; Ertl, HCJ
      Vaccine regimen for prevention of sexually transmitted infections with human papillomavirus type 16

      VACCINE
    48. Shiau, AL; Chu, CY; Su, WC; Wu, CL
      Vaccination with the glycoprotein D gene of pseudorabies virus delivered by nonpathogenic Escherichia coli elicits protective immune responses

      VACCINE
    49. Nardelli-Haefliger, D; Benyacoub, J; Lemoine, R; Hopkins-Donaldson, S; Potts, A; Hartman, F; Kraehenbuhl, JP; De Grandi, P
      Nasal vaccination with attenuated Salmonella typhimurium strains expressing the Hepatitis B nucleocapsid: dose response analysis

      VACCINE
    50. El Kasmi, KC; Muller, CP
      New strategies for closing the gap of measles susceptibility in infants: towards vaccines compatible with current vaccination schedules

      VACCINE
    51. Evans, TG; McElrath, MJ; Matthews, T; Montefiori, D; Weinhold, K; Wolff, M; Keefer, MC; Kallas, EG; Corey, L; Gorse, GJ; Belshe, R; Graham, BS; Spearman, PW; Schwartz, D; Mulligan, MJ; Goepfert, P; Fast, P; Berman, P; Powell, M; Francis, D
      QS-21 promotes an adjuvant effect allowing for reduced antigen dose duringHIV-1 envelope subunit immmunization in humans

      VACCINE
    52. Huang, Z; Dry, I; Webster, D; Strugnell, R; Wesselingh, S
      Plant-derived measles virus hemagglutinin protein induces neutralizing antibodies in mice

      VACCINE
    53. Buonaguro, L; Buonaguro, FM; Tornesello, ML; Mantas, D; Beth-Giraldo, E; Wagner, R; Michelson, S; Prevost, MC; Wolf, H; Giraldo, G
      High efficient production of Pr55(gag) virus-like particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype A

      ANTIVIRAL RESEARCH
    54. Broliden, K; Hinkula, J; Devito, C; Kiama, P; Kimani, J; Trabbatoni, D; Bwayo, JJ; Clerici, M; Plummer, F; Kaul, R
      Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers

      IMMUNOLOGY LETTERS
    55. Cherpelis, S; Jin, X; Gettie, A; Ho, DD; Barnett, SW; Shrivastava, I; Stamatatos, L
      DNA-immunization with a V2 deleted HIV-1 envelope elicits protective antibodies in macaques

      IMMUNOLOGY LETTERS
    56. Xiao, Y; Lu, Y; Chen, YH
      Epitope-vaccine as a new strategy against HIV-1 mutation

      IMMUNOLOGY LETTERS
    57. Hadlock, KG; Gish, R; Rowe, J; Rajyaguru, SS; Newsom, M; Warford, A; Foung, SKH
      Cross-reactivity and clinical impact of the antibody response to hepatitisC virus second envelope glycoprotein (E2)

      JOURNAL OF MEDICAL VIROLOGY
    58. Munoz, I; Gutierrez, A; Gimeno, C; Farga, A; Alberola, J; Solano, C; Prosper, F; Garcia-Conde, J; Navarro, D
      Lack of association between the kinetics of human cytomegalovirus (HCMV) glycoprotein B (gB)-specific and neutralizing serum antibodies and development or recovery from HCMV active infection in patients undergoing allogeneicstem cell transplant

      JOURNAL OF MEDICAL VIROLOGY
    59. Alberola, J; Tamarit, A; Cardenoso, L; Estelles, F; Igual, R; Navarro, D
      Longitudinal analysis of human cytomegalovirus glycoprotein B (gB)-specific and neutralizing antibodies in AIDS patients either with or without cytomegalovirus end-organ disease

      JOURNAL OF MEDICAL VIROLOGY
    60. Cusi, MG; Valensin, PE; Donati, M; Valassina, M
      Neutralization of Toscana virus is partially mediated by antibodies to thenucleocapsid protein

      JOURNAL OF MEDICAL VIROLOGY
    61. Parren, PWHI; Burton, DR
      The antiviral activity of antibodies in vitro and in vivo

      ADVANCES IN IMMUNOLOGY, VOL 77
    62. Hofmann-Lehmann, R; Rasmussen, RA; Vlasak, J; Smith, BA; Baba, TW; Liska, V; Montefiori, DC; McClure, HM; Anderson, DC; Bernacky, BJ; Rizvi, TA; Schmidt, R; Hill, LR; Keeling, ME; Katinger, H; Stiegler, G; Posner, MR; Cavacini, LA; Chou, TC; Ruprecht, RM
      Passive immunization against oral AIDS virus transmission: An approach to prevent mother-to-infant HIV-1 transmission?

      JOURNAL OF MEDICAL PRIMATOLOGY
    63. Wallengren, K; Risco, C; Krijnse-Locker, J; Esteban, M; Rodriguez, D
      The A17L gene product of vaccinia virus is exposed on the surface of IMV

      VIROLOGY
    64. Kutinova, L; Hainz, P; Ludvikova, V; Maresova, L; Nemeckova, S
      Immune response to vaccinia virus recombinants expressing glycoproteins gE, gB, gH, and gL of Varicella-zoster virus

      VIROLOGY
    65. Spenlehauer, C; Gordon, CA; Trkola, A; Moore, JP
      A luciferase-reporter gene-expressing T-cell line facilitates neutralization and drug-sensitivity assays that use either R5 or X4 strains of human immunodeficiency virus type 1

      VIROLOGY
    66. Kumar, A; Buch, S; Foresman, L; Bischofberger, N; Lifson, JD; Narayan, O
      Development of virus-specific immune responses in SHIVKU-infected macaquestreated with PMPA

      VIROLOGY
    67. Revaz, V; Benyacoub, J; Kast, WM; Schiller, JT; De Grandi, P; Nardelli-Haefliger, D
      Mucosal vaccination with a recombinant Salmonella typhimurium expressing human papillomavirus type 16 (HPV16) L1 virus-like particles (VLPs) or HPV16VLPs purified from insect cells inhibits the growth of HPV16-expressing tumor cells in mice

      VIROLOGY
    68. Amara, RR; Villinger, F; Altman, JD; Lydy, SL; O'Neil, SP; Staprans, SI; Montefiori, DC; Xu, Y; Herndon, JG; Wyatt, LS; Candido, MA; Kozyr, NL; Earl, PL; Smith, JM; Ma, HL; Grimm, BD; Hulsey, ML; Miller, J; McClure, HM; McNicholl, JM; Moss, B; Robinson, HL
      Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine

      SCIENCE
    69. Oentrich, W; Dose, T; Friedmann, D; Haupts, M; Haller, P; Hartung, HP; Walther, EU; Konig, N; Schroder, G; Sturzebecher, CS
      Course of interferon beta-1b (Betaferon (R)) therapy in patients with relapsing-remitting multiple sclerosis. Survey results

      NERVENARZT
    70. Maurer, M; Gold, R; Toyka, KV; Rieckmann, P
      Treatment of multiple sclerosis with recombinant interferon-beta preparations. Views on pharmocology and dosage

      NERVENARZT
    71. Nabel, GJ
      Challenges and opportunities for development of an AIDS vaccine

      NATURE
    72. Ortiz, GM; Wellons, M; Brancato, J; Vo, HTT; Zinn, RL; Clarkson, DE; Van Loon, K; Bonhoeffer, S; Miralles, GD; Montefiori, D; Bartlett, JA; Nixon, DF
      Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    73. Bolmstedt, AJ; O'Keefe, BR; Shenoy, SR; Mcmahon, JB; Boyd, MR
      HIV-inhibitory natural products part 71 - Cyanovirin-N defines a new classof antiviral agent targeting N-linked, high-mannose glycans in an oligosaccharide-specific manner

      MOLECULAR PHARMACOLOGY
    74. Letvin, NL; Robinson, S; Rohne, D; Axthelm, MK; Fanton, JW; Bilska, M; Palker, TJ; Liao, HX; Haynes, BF; Montefiori, DC
      Vaccine-elicited V3 loop-specific antibodies in rhesus monkeys and controlof a simian-human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate envelope

      JOURNAL OF VIROLOGY
    75. McGettigan, JP; Foley, HD; Belyakov, IM; Berzofsky, JA; Pomerantz, RJ; Schnell, MJ
      Rabies virus-based vectors expressing human immunodeficiency virus type 1 (HIV-1) envelope protein induce a strong, cross-reactive cytotoxic T-lymphocyte response against envelope proteins from different HIV-1 isolates

      JOURNAL OF VIROLOGY
    76. Netter, HJ; MacNaughton, TB; Woo, WP; Tindle, R; Gowans, EJ
      Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes

      JOURNAL OF VIROLOGY
    77. Delorme, C; Brussow, H; Sidoti, J; Roche, N; Karlsson, KA; Neeser, JR; Teneberg, S
      Glycosphingolipid binding specificities of rotavirus: Identification of a sialic acid-binding epitope

      JOURNAL OF VIROLOGY
    78. Slifka, MK; Pagarigan, R; Mena, I; Feuer, R; Whitton, JL
      Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8(+) T cells during picornavirus infection

      JOURNAL OF VIROLOGY
    79. Morrison, LA; Zhu, L; Thebeau, LG
      Vaccine-induced serum immunoglobin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells

      JOURNAL OF VIROLOGY
    80. Hioe, CE; Tuen, M; Chien, PC; Jones, G; Ratto-Kim, S; Norris, PJ; Moretto, WJ; Nixon, DF; Gorny, MK; Zolla-Pazner, S
      Inhibition of human immunodeficiency virus type 1 gp120 presentation to CD4 T cells by antibodies specific for the CD4 binding domain of gp120

      JOURNAL OF VIROLOGY
    81. Shi, W; Liu, JZ; Huang, YJ; Qiao, L
      Papillomavirus pseudovirus: A novel vaccine to induce mucosal and systemiccytotoxic T-lymphocyte responses

      JOURNAL OF VIROLOGY
    82. Maresova, L; Pasieka, TJ; Grose, C
      Varicella-zoster virus gB and gE coexpression, but not gB or gE alone, leads to abundant fusion and syncytium formation equivalent to those from gH and gL coexpression

      JOURNAL OF VIROLOGY
    83. McGettigan, JP; Sarma, S; Orenstein, JM; Pomerantz, RJ; Schnell, MJ
      Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector

      JOURNAL OF VIROLOGY
    84. Crotty, S; Miller, CJ; Lohman, BL; Neagu, MR; Compton, L; Lu, D; Lu, FXS; Fritts, L; Lifson, JD; Andino, R
      Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors

      JOURNAL OF VIROLOGY
    85. Hofmann-Lehmann, R; Vlasak, J; Rasmussen, RA; Smith, BA; Baba, TW; Liska, V; Ferrantelli, F; Montefiori, DC; McClure, HM; Anderson, DC; Bernacky, BJ; Rizvi, TA; Schmidt, R; Hill, LR; Keeling, ME; Katinger, H; Stiegler, G; Cavacini, LA; Posner, MR; Chou, TC; Andersen, J; Ruprecht, RM
      Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge

      JOURNAL OF VIROLOGY
    86. Fligge, C; Schafer, F; Selinka, HC; Sapp, C; Sapp, M
      DNA-induced structural changes in the papillomavirus capsid

      JOURNAL OF VIROLOGY
    87. Gerber, S; Lane, C; Brown, DM; Lord, E; Dilorenzo, M; Clements, JD; Rybicki, E; Williamson, AL; Rose, RC
      Human papillomavirus virus-like particles are efficient oral immunogens when coadministered with Escherichia coli heat-labile enterotoxin mutant R192G or CpG DNA

      JOURNAL OF VIROLOGY
    88. Lundstrom, JO; Lindstrom, KM; Olsen, B; Dufva, R; Krakower, DS
      Prevalence of Sindbis virus neutralizing antibodies among Swedish passerines indicates that thrushes are the main amplifying hosts

      JOURNAL OF MEDICAL ENTOMOLOGY
    89. Corey, L
      Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 Env, Gag, and Pro in combination with RGP120

      JOURNAL OF INFECTIOUS DISEASES
    90. Crowe, JE; Firestone, CY; Murphy, BR
      Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines

      JOURNAL OF IMMUNOLOGY
    91. Bertolotto, A; Gilli, F; Sala, A; Audano, L; Castello, A; Magliola, U; Melis, F; Giordana, MT
      Evaluation of bioavailability of three types of IFN beta in multiple sclerosis patients by a new quantitative-competitive-PCR method for MxA quantification

      JOURNAL OF IMMUNOLOGICAL METHODS
    92. Clark, B; Caparros-Wanderley, W; Musselwhite, G; Kotecha, M; Griffin, BE
      Immunity against both polyomavirus VP1 and a transgene product induced following intranasal delivery of VP1 pseudocapsid-DNA complexes

      JOURNAL OF GENERAL VIROLOGY
    93. Da Silva, DM; Eiben, GL; Fausch, SC; Wakabayashi, MT; Rudolf, MP; Velders, MP; Kast, WM
      Cervical cancer vaccines: Emerging concepts and developments

      JOURNAL OF CELLULAR PHYSIOLOGY
    94. Theiler, RN; Compton, T
      Characterization of the signal peptide processing and membrane associationof human cytomegalovirus glycoprotein O

      JOURNAL OF BIOLOGICAL CHEMISTRY
    95. Brochier, J; Liautard, J; Jacquet, C; Gaillard, JP; Klein, B
      Optimizing therapeutic strategies to inhibit circulating soluble target molecules with monoclonal antibodies: example of the soluble IL-6 receptors

      EUROPEAN JOURNAL OF IMMUNOLOGY
    96. Hamaia, S; Li, CY; Allain, JP
      The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines

      BLOOD
    97. Patterson, LJ; Aberdeen, A; Kone, J; Haben, M; Raymond, M; Berkower, I
      Formation of HIV-1 envelope-hepatitis B core antigen hybrids with high affinity for CD4

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    98. Smiley, JR; Jackwood, DJ
      Genetic stability of the VP2 hypervariable region of four infectious bursal disease virus isolates after serial passage in specific-pathogen-free chicken embryos

      AVIAN DISEASES
    99. Pachner, AR
      Measurement of antibodies to interferon beta in patients with multiple sclerosis

      ARCHIVES OF NEUROLOGY
    100. Cunningham, MW
      Cardiac myosin and the TH1/TH2 paradigm in autoimmune myocarditis

      AMERICAN JOURNAL OF PATHOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/05/20 alle ore 21:39:50